Ioannides C - Search Results

1

Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease.

Hayes PC, Jenkins D, Vavianos P, Dagap K, Johnston A, Ioannides C, Thomas P, Williams R. Hayes PC, et al. Among authors: ioannides c. Eur Heart J. 1987 Dec;8 Suppl M:23-9. doi: 10.1093/eurheartj/8.suppl_m.23. Eur Heart J. 1987. PMID: 2897298

2

The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.

Payton CD, Fox JG, Pauleau NF, Boulton-Jones JM, Ioannides C, Johnston A, Thomas P. Payton CD, et al. Among authors: ioannides c. Eur Heart J. 1987 Dec;8 Suppl M:15-22. doi: 10.1093/eurheartj/8.suppl_m.15. Eur Heart J. 1987. PMID: 2897297

3

A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.

Lewis R, Maclean D, Ioannides C, Johnston A, McDevitt DG. Lewis R, et al. Among authors: ioannides c. Br J Clin Pharmacol. 1988 Jul;26(1):53-9. doi: 10.1111/j.1365-2125.1988.tb03363.x. Br J Clin Pharmacol. 1988. PMID: 2904825 Free PMC article. Clinical Trial.

4

Mutagenicity testing of 9-N-substituted adenines and their N-oxidation products.

Gorrod JW, Ioannides C, Lam SP, Neville S. Gorrod JW, et al. Among authors: ioannides c. Environ Health Perspect. 1993 Oct;101 Suppl 3(Suppl 3):21-6. doi: 10.1289/ehp.93101s321. Environ Health Perspect. 1993. PMID: 8143619 Free PMC article.

5

Elimination of glyceryl trinitrate: effects of sex, age, species and route of administration.

Ioannides C, Parke DV, Taylor IW. Ioannides C, et al. Br J Pharmacol. 1982 Sep;77(1):83-8. doi: 10.1111/j.1476-5381.1982.tb09272.x. Br J Pharmacol. 1982. PMID: 6812676 Free PMC article.

6

A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls.

Ioannides C, Lewis DF, Trinick J, Neville S, Sertkaya NN, Kajbaf M, Gorrod JW. Ioannides C, et al. Carcinogenesis. 1989 Aug;10(8):1403-7. doi: 10.1093/carcin/10.8.1403. Carcinogenesis. 1989. PMID: 2665965

7

A study of the mutagenicity of melatonin and 6-hydroxymelatonin.

Neville S, Arendt J, Ioannides C. Neville S, et al. Among authors: ioannides c. J Pineal Res. 1989;6(1):73-6. doi: 10.1111/j.1600-079x.1989.tb00404.x. J Pineal Res. 1989. PMID: 2646423

8

The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.

Masson HA, Ioannides C, Gorrod JW, Gibson GG. Masson HA, et al. Among authors: ioannides c. Carcinogenesis. 1983 Dec;4(12):1583-6. doi: 10.1093/carcin/4.12.1583. Carcinogenesis. 1983. PMID: 6418403

9

Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.

Ayrton AD, Neville S, Ioannides C. Ayrton AD, et al. Among authors: ioannides c. Mutat Res. 1992 Jan;265(1):1-8. doi: 10.1016/0027-5107(92)90034-y. Mutat Res. 1992. PMID: 1370238

10

The metabolic activation of 2-naphthylamine to mutagens in the Ames test.

Tong S, Smith J, Manson D, Gorrod JW, Ioannides C. Tong S, et al. Among authors: ioannides c. Anticancer Res. 1986 Sep-Oct;6(5):1107-12. Anticancer Res. 1986. PMID: 3800318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters